v3.26.1
STOCKHOLDERS' EQUITY (Details) - USD ($)
 1 Months Ended 3 Months Ended
Mar. 13, 2026
Jan. 20, 2026
Feb. 24, 2025
Feb. 18, 2025
Feb. 05, 2025
Jan. 28, 2025
Mar. 31, 2022
Mar. 25, 2026
Jan. 22, 2026
Oct. 31, 2025
Nov. 30, 2024
Mar. 31, 2026
Mar. 31, 2025
Mar. 11, 2026
Mar. 02, 2026
Jan. 14, 2026
Dec. 31, 2025
Sep. 05, 2025
Sep. 30, 2024
Stockholders’ Equity [Line Items]                                      
Common stock shares authorized                       150,000,000         150,000,000    
Common stock par value (in dollars per share)                       $ 0.0001         $ 0.0001    
Common stock, shares issued                       2,636,788         1,163,142    
Common stock outstanding   1,359,091 1,472,891 7,364,554               2,636,788       5,436,441 1,163,142    
Reverse stock split   1:4 1:5 1:5           Following stockholder approval in October 2025, the Company effected an additional reverse stock split at a ratio of 1:4 (the “1:4 Reverse Stock Split” and together with the 1:5 Reverse Stock Split, the “Reverse Stock Splits”). Following stockholder approval in November 2024, the Company effected a reverse stock split at a ratio of 1:5, which was effective as of February 4, 2025 (the “1:5 Reverse Stock Split”). 1:4 1:5            
Exercise of warrants                                     96,300
Dividends percentage                       6.00%              
Dividends preferred stock                       $ 1,330,383              
Shares converted             4,619                        
Proceeds from Exercise of Pre-Funded Warrants                       $ 1,926            
Net Proceeds from February 2025 Offering                       $ 908,627            
Warrants, each warrant to purchase one share of Common Stock                                      
Stockholders’ Equity [Line Items]                                      
Number of Warrants, Exercised                       (96,300)            
Number of warrants granted                       186,807            
Number of warrants exercisable                       1,896,928 531,784            
Weighted average exercise price (in dollars per share)                         $ 0.02            
Pre-Funded Warrant [Member]                                      
Stockholders’ Equity [Line Items]                                      
Exercise of warrants                         0            
Number of Warrants, Exercised                       0 96,300            
Proceeds from Exercise of Pre-Funded Warrants                       $ 0 $ 1,926            
Issuance of common stock upon exercise of Pre-Funded Warrants (in shares)                       0 96,300            
2025 ATM Agreement [Member]                                      
Stockholders’ Equity [Line Items]                                      
Sale of stock price per share (in dollars per share)                 $ 2.07                    
ATM Offering                 418,602                    
Proceeds from common stock sales agreement net                 $ 834,705                    
2026 ATM Offering [Member]                                      
Stockholders’ Equity [Line Items]                                      
Sale of stock price per share (in dollars per share)               $ 2.49                      
ATM Offering               1,055,106                      
Proceeds from common stock sales agreement net               $ 2,535,047                      
Common stock aggregate gross sales proceeds authorized                             $ 1,308,000        
Increased common stock aggregate gross sales proceeds authorized                           $ 981,000          
January 2025 Offering [Member]                                      
Stockholders’ Equity [Line Items]                                      
Net proceeds from Private Placement           $ 804,346                          
Issuance of common stock and warrants pursuant to January 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares)           51,079                          
January 2025 Offering [Member] | January 2025 Warrants [Member]                                      
Stockholders’ Equity [Line Items]                                      
Exercise of warrants           102,158                          
Exercise price of warrants (in dollars per share)           $ 15.42                          
Class of Warrant or Rights Expiry Term           24 months                          
January 2025 Offering [Member] | January 2025 Agent Warrants [Member]                                      
Stockholders’ Equity [Line Items]                                      
Exercise of warrants           3,833                          
Exercise price of warrants (in dollars per share)           $ 25.53                          
Class of Warrant or Rights Expiry Term           24 months                          
February 2025 Offering [Member]                                      
Stockholders’ Equity [Line Items]                                      
Issuance of common stock and warrants pursuant to January 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares)         75,176                            
Net Proceeds from February 2025 Offering         $ 908,627                            
February 2025 Offering [Member] | January 2025 Warrants [Member]                                      
Stockholders’ Equity [Line Items]                                      
Date from which warrants exercisable           Jan. 30, 2025                          
February 2025 Offering [Member] | February 2025 Warrants [Member]                                      
Stockholders’ Equity [Line Items]                                      
Exercise of warrants         75,176                            
Exercise price of warrants (in dollars per share)         $ 11.8                            
Class of Warrant or Rights Expiry Term         24 months                            
February 2025 Offering [Member] | February 2025 Agent Warrants [Member]                                      
Stockholders’ Equity [Line Items]                                      
Exercise of warrants         5,640                            
Exercise price of warrants (in dollars per share)         $ 17.88                            
Class of Warrant or Rights Expiry Term         24 months                            
Common Stock, par value $0.0001 per share                                      
Stockholders’ Equity [Line Items]                                      
Issuance of common stock upon exercise of Pre-Funded Warrants (in shares) [1]                         96,300            
Issuance of common stock and warrants pursuant to January 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares) [1]                         51,079            
Common Stock, par value $0.0001 per share | January 2025 Offering [Member]                                      
Stockholders’ Equity [Line Items]                                      
Sale of stock price per share (in dollars per share)           $ 20.42                          
Common Stock, par value $0.0001 per share | February 2025 Offering [Member]                                      
Stockholders’ Equity [Line Items]                                      
Sale of stock price per share (in dollars per share)         $ 14.3                            
H C Wainwright And Co LLC [Member] | 2025 ATM Agreement [Member]                                      
Stockholders’ Equity [Line Items]                                      
Common stock aggregate gross sales proceeds authorized                                   $ 1,397,532  
Sales agent commission percentage                                   3.00%  
H C Wainwright And Co LLC [Member] | 2026 ATM Offering [Member]                                      
Stockholders’ Equity [Line Items]                                      
Sales agent commission percentage                             3.00%        
H C Wainwright And Co LLC [Member] | March 2026 At-the-Market Agreement [Member]                                      
Stockholders’ Equity [Line Items]                                      
Common stock aggregate gross sales proceeds authorized increase $ 565,000                                    
Series A Preferred Stock [Member]                                      
Stockholders’ Equity [Line Items]                                      
Preferred stock converted shares (in Dollars per share)                       $ 1,200              
Preferred stock shares authorized                       1,000,000         1,000,000    
Preferred stock shares, par value (in dollars per share)                       $ 0.0001         $ 0.0001    
Preferred stock shares issued                       76,480         76,480    
Preferred stock shares outstanding                       76,480         76,480    
Dividends percentage                       19.90%              
Dividends preferred stock                       $ 125,312 $ 118,158            
Common stock conversion price per share (in dollars per share)                       $ 100              
Series A Non-Voting Convertible Preferred Stock [Member]                                      
Stockholders’ Equity [Line Items]                                      
Designated shares             80,965         80,965              
[1] Prior periods presented have been adjusted to reflect the 1:4 reverse stock split on January 20, 2026.